FAKTOR-OPTIONSSCHEIN - PFIZER INC | Delayed Deutsche Boerse AG 12:19:10 03/06/2024 BST | ||
| 1.7 EUR | -3.95% |
|
| 1 month | -54.50% | ||
| 3 months | -49.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 1.7 | -3.95% |
| 31/05/24 | 1.77 | -6.35% |
| 30/05/24 | 1.89 | -3.57% |
| 29/05/24 | 1.96 | +7.69% |
| 28/05/24 | 1.82 | +13.75% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 12:19 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| WKN | SF2U68 |
| ISIN | DE000SF2U685 |
| Date issued | 23/07/2021 |
| Strike | 41.04 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.78 € |
|---|---|
| Lowest since issue | 0.26 € |
| Spread | 0.02 € |
| Spread % | 1.16% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Certificates
- Certificat
